Dose timing in tumor radiotherapy: Considerations of cell number stochasticity

Mathematical Biosciences

Volumn 138, Issue 2, 1996, Pages 131-146

  Sachs, Rainer K ^a   Heidenreich, Wolfgang F ^b   Brenner, David J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CELL GROWTH; CELL KILLING; MATHEMATICAL MODEL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TUMOR CELL; X IRRADIATION;

EID: 0030561336     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(96)00128-9     Document Type: Article

References (39)

1. 1 H. D. Thames and J. H. Hendry, Fractionation in Radiotherapy, Taylor & Francis, London, 1987.
2. 2 E. J. Hall, Radiobiology for the Radiobiologist, 4th ed., Lippincott, Philadelphia, 1994, Chaps. 12 and 13.
3. 3 L. Hlatky, P. Hahnfeldt, and R. K. Sachs, The influence of time-dependent, stochastic heterogeneity on the radiation response of a cell population, Math. Biosci. 122:201-220 (1994).
4. 4 P-L. Chen, D. J. Brenner, and R. K. Sachs, Ionizing radiation damage to cells: Effects of cell cycle redistribution, Math. Biosci. 126:147-170 (1995).
5. 5 D. J. Brenner, L. R. Hlatky, P. J. Hahnfeldt, E. J. Hall, and R. K. Sachs, A convenient extension of the linear-quadratic model to include redistribution and reoxygenation, Int. J. Radiat. Oncol. Biol. Phys. 32:379-390 (1995).
6. 6 H. R. Withers, J. M. G. Taylor, and B. Maciejewski, The hazard of accelerated tumor clonogen repopulation during radiotherapy, Acta Oncol. 27:131-146 (1988).
7. 7 R. D. Cox, T. F. Pajak, S. Asbell, A. H. Russell, J. Pederson, R. W. Byhardt, B. Emami, and M. Roach 3d, Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials, Int. J. Radiat. Oncol. Biol Phys. 27:493-498 (1993).
8. 8 J. H. Hendry, S. A. Roberts, N. J. Slevin, T. J. Keane, M. B. Barton, and A. Agren-Cronqvist, Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother. Oncol. 31:14-22 (1994).
9. 9 D. G. Petereit, J. N. Sarkaria, R. Chappell, J. F. Fowler, T. J. Hartmann, T. J. Kinsella, J. A. Stitt, B. R. Thomadsen, and D. A. Buchler, The adverse effect of treatment prolongation in cervical carcinoma [see comments]. Int. J. Radiat. Oncol. Biol. Phys. 32:1301-1307 (1995).
10. 10 S. A. Roberts, J. H. Hendry, A. E. Brewster, and N. J. Slevin, The influence of radiotherapy treatment time on the control of laryngeal cancer: A direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor, Br. J. Radiol. 67:790-794 (1994).
11. 11 A. Y. Yakovlev and A. V. Zorin, Computer Simulation in Cell Radiobiology, Springer-Verlag, Berlin, 1988.
12. 12 S. L. Tucker, H. D. Thames, and J. M. G. Taylor, How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat. Res. 124:273-282 (1990).
13. 13 D. J. Brenner, E. J. Hall, Y. Huang, and R. K. Sachs, Optimizing the time course of brachytherapy and other accelerated radiotherapeutic protocols, Int. J. Radiat. Oncol. Biol. Phys. 29:893-901 (1994).
14. 14 L. Hanin, L. V. Pavlova, and A. Y. Yakovlev, Biomathematical Problems in Optimization of Cancer Radiotherapy, CRC Press, Boca Raton, 1994.
15. 15 S. L. Tucker and J. M. G. Taylor, Improved models of tumor cure, Int. J. Radiat. Biol., in press (1996).
16. 16 R. Chappell, D. M. Nondahl, M. Rezvani, and J. F. Fowler, Further analysis of radiobiological parameters from the First and Second British Institute of Radiology randomized studies of larynx/pharynx radiotherapy, Int. J. Radiat. Oncol. Biol. Phys. 33 (1995).
17. 17 A. Y. Yakovlev and N. M. Yanev, Transient Processes in Cell Proliferation Kinetics (B. I. Grudinko, translator), Springer-Verlag, Lecture Notes in Biomathematics, 1989.
18. 18 S. P. Lee, M. Y. Leu, J. B. Smathers, W. H. McBride, R. G. Parker, and H. R. Withers, Biologically effective dose distribution based on the linear quadratic model and its clinical relevance, Int. J. Radiat. Oncol. Biol. Phys. 33:375-389 (1995).
19. 19 J. F. Fowler, Rapid repopulation in radiotherapy: A debate on mechanism. The phantom of tumor treatment - continually rapid proliferation unmasked. Radiother. Oncol. 22:156-158 (1991).
20. 20 J. H. Hendry, C. M. West, J. V. Moore, and C. S. Potten, Tumour stem cells: The relevance of predictive assays for tumour control after radiotherapy [comment]. Radiother. Oncol. 30:11-16 (1994).
21. 21 K. R. Trott, Tumour stem cells: The biological concept and its application in cancer treatment, Radiother. Oncol. 30:1-5 (1994).
22. 22 W. Feller, An Introduction to Probability Theory and Its Applications, 3rd ed., Vol. 1, Wiley, New York, 1968, pp. 454 ff, 480 ff.
23. 23 S. H. Moolgavkar and G. Luebeck, Two-event model for carcinogenesis: Biological mathematical, and statistical considerations, Risk Anal. 10:323-341 (1990).
24. 24 G. K. Zagars, T. E. Schultheiss, and L. D. Peters, Inter-tumor heterogeneity and radiation dose-control curves, Radiother. Oncol. 8:353-362 (1987).
25. 25 H. Suit, S. Skates, A. Taghian, P. Okunieff, and J. T. Efird, Clinical implications of heterogeneity of tumor response to radiation therapy, Radiother. Oncol. 25:251-260, 1992.
26. 26 S. L. Tucker and E. L. Travis, Comments on a time-dependent version of the linear-quadratic model, Radiother. Oncol. 18:155-163 (1990).
27. 27 D. J. Brenner, Accelerated repopulation during radiotherapy: Quantitative evidence for delayed onset, Radiat. Oncol. Invest. 1:167-172 (1993).
28. 28 S. A. Roberts and J. H. Hendry, The delay before onset of accelerated tumour cell repopulation during radiotherapy: A direct maximum-likelihood analysis of a collection of worldwide tumour-control data, Radiother. Oncol. 29:69-74 (1993).
29. 29 W. F. Heidenreich, On the parameters of the clonal expansion model, Radiat. Environ. Biophys. 35:127-129 (1996).
30. 30 W. F. Heidenreich, P. Jacob, and H. G. Paretzke, Exact solutions of the clonal expansion model and their application to the tumor incidence of the atomic bomb survivors, Radiat. Environ. Biophys., in press (1996).
31. 31 R. K. Sachs, P-L. Chen, P. J. Hahnfeldt, and L. R. Hlatky, DNA damage caused by ionizing radiation, Math. Biosci. 112:271-303 (1992).
32. 32 E. C. Zachmanoglou and D. W. Thoe, Introduction to Partial Differential Equations with Applications, Williams & Wilkins, Baltimore, 1976, Chap. III.
33. 33 P. Hahnfeldt and R. K. Sachs, Radiation damage to a dynamic cell population, in Proceedings, 4th International Conference on Population Dynamics (Arino, Ed.), 1996.
34. 34 R. K. Sachs, L. Shapiro, L. R. Hlatky, E. J. Hall, and D. J. Brenner, A computer code for treatment compensation after unplanned interruptions during radiotherapy, CPAM Report, UC Berkeley Math. Dept. 618, 1994.
35. 35 A. Y. Yakovlev, Comments on the distribution of clonogens in irradiated tumors, Radiat. Res. 134:117-120 (1993).
36. 36 J. M. G. Taylor, S. L. Tucker, and H. D. Thames, The probability of tumor cure: Response to comments by Dr. Yakovlev, Radiat. Res. 134:121-122 (1993).
37. 37 S. M. Bentzen, Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carinoma, Int. J. Radiat. Biol. 61:417-423 (1992).
38. 38 H. D. Thames, T. E. Schultheiss, J. H. Hendry, S. L. Tucker, B. M. Dubray, and W. A. Brock, Can modest escalations of dose be detected as increased tumor control? Int. J. Radiat. Oncol. Biol. Phys. 22:241-246 (1991).
39. 39 S. L. Tucker and H. D. Thames, The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: A theoretical evaluation, Int. J. Radiat. Oncol. Biol. Phys. 17:145-157 (1989).